Share Search
Visit the Share Search
OptiBiotix Health Accounts Summary
| Date of Accounts | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Standard | IFRS | IFRS | IFRS | IFRS | IFRS |
| Millions | Millions | Millions | Millions | Millions | |
| Income Statement | 31-12-2025 | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 |
| Revenue | 1.17 | 0.87 | 0.64 | 0.46 | 2.21 |
| Operating Profit / Loss | -3,132.00 | -2.27 | -1.70 | -2.49 | -1.36 |
| Net Interest | n/a | n/a | n/a | n/a | -0.05 |
| Pre Tax Profit | -3.94 | -1.87 | -2.04 | 2.44 | 6.18 |
| Post Tax Profit | -3.89 | -1.80 | -2.04 | 2.59 | 6.26 |
| Profit for the Period | -3.89 | -1.80 | -2.04 | 2.59 | 6.26 |
| Equity Holders of Parent Company | -3.89 | -1.80 | -2.04 | 2.59 | 6.26 |
| Minority Interests | n/a | n/a | n/a | n/a | n/a |
| Continuing EPS | |||||
| Earnings per Share (Basic) | -3.84p | -1.84p | -2.24p | 2.93p | 7.15p |
| Earnings per Share (Diluted) | -3.84p | -1.84p | -2.24p | 2.78p | 6.55p |
| Earnings per Share (Adjusted) | -3.84p | -1.84p | -2.24p | 2.93p | 7.15p |
| Continuing and Discontinued EPS | |||||
| Earnings per Share (Basic) | -3.84p | -1.84p | -2.24p | 2.93p | 7.15p |
| Earnings per Share (Diluted) | -3.84p | -1.84p | -2.24p | 2.78p | 6.55p |
| Earnings per Share (Adjusted) | -3.84p | -1.84p | -2.24p | 2.93p | 7.15p |
| Dividend per Share | n/ap | n/ap | n/ap | n/ap | n/ap |
| Millions | Millions | Millions | Millions | Millions | |
| Balance Sheet | 31-12-2025 | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 |
| Non-Current Assets | |||||
| Intangible Assets | 0.91 | 1.12 | 1.33 | 1.54 | 2.64 |
| Property, Plant and Equipment | n/a | n/a | n/a | n/a | n/a |
| Investments | 4.34 | 6.50 | 6.69 | 8.15 | 13.65 |
| Investment Properties | n/a | n/a | n/a | n/a | n/a |
| Other Financial Assets | n/a | n/a | n/a | n/a | n/a |
| Other Non-Current Assets | n/a | n/a | n/a | n/a | n/a |
| Total Non-Current Assets | 5.25 | 7.62 | 8.02 | 9.69 | 16.29 |
| Current Assets | |||||
| Inventories | 0.30 | 0.23 | 0.19 | 0.18 | 0.10 |
| Trade and Other Receivables | 0.28 | 0.43 | 0.46 | 0.52 | 1.55 |
| Cash at Bank and in Hand | 1.04 | 0.74 | 0.64 | 1.05 | 2.01 |
| Current Asset Investments | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 0.02 | 0.02 | 0.10 | 0.11 | 0.19 |
| Total Current Assets | 1.64 | 1.42 | 1.38 | 1.86 | 3.85 |
| Other Assets | n/a | n/a | n/a | n/a | n/a |
| Total Assets | 6.89 | 9.04 | 9.40 | 11.55 | 20.14 |
| Current Liabilities | |||||
| Borrowings | n/a | n/a | n/a | n/a | n/a |
| Other Current Liabilities | 0.38 | 0.37 | 0.18 | 0.28 | 0.60 |
| Total Current Liabilities | 0.38 | 0.37 | 0.18 | 0.28 | 0.60 |
| Net Current Assets | n/a | n/a | n/a | n/a | n/a |
| Non-Current Liabilities | |||||
| Borrowings | n/a | n/a | n/a | 0.37 | 0.82 |
| Provisions | 0.23 | 0.28 | 0.35 | n/a | 0.55 |
| Other Non-Current Liabilities | n/a | n/a | n/a | n/a | n/a |
| Total Non-Current Liabilities | 0.23 | 0.28 | 0.35 | 0.37 | 1.37 |
| Net Assets | 6.28 | 8.40 | 8.87 | 10.90 | 18.17 |
| Capital and Reserves | |||||
| Share Capital | 2.07 | 1.96 | 1.82 | 1.82 | 1.76 |
| Share Premium Account | 4.71 | 4.11 | 2.96 | 2.96 | 2.54 |
| Other Reserves | 2.81 | 1.75 | 2.27 | 2.44 | 2.52 |
| Retained Earnings | -3.31 | 0.58 | 1.82 | 3.68 | 11.32 |
| Shareholders Funds | 6.28 | 8.40 | 8.87 | 10.90 | 18.14 |
| Minority Interests / Other Equity | n/a | n/a | n/a | n/a | 0.04 |
| Total Equity | 6.28 | 8.40 | 8.87 | 10.90 | 18.17 |
| 31-12-2025 | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 | |
| Operating Margin | -268,610.63% | -260.46% | -263.35% | -544.64% | -61.68% |
| Return on Capital Employed | -70.46% | -24.70% | -25.90% | 25.09% | 36.83% |
| Dividend Cover | n/a | n/a | n/a | n/a | n/a |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | n/a | n/a | n/a | 4.50 | 6.40 |
| PEG | n/a | n/a | n/a | n/a | 0.80 |
| Dividend per Share Growth | n/a% | n/a% | n/a% | n/a% | n/a% |
| Net Asset Value per Share | 5.20p | 7.05p | 7.30p | 9.07p | 15.04p |